Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Randomised, Double-blind, 3-parallel -Group Phase I Study of BFI-751 Compared With EU-STELARA® and US-STELARA® in Healthy Adult Volunteers

NCT04843631 is registered in ClinicalTrials.gov with BioFactura Australia Pty Ltd. as lead sponsor.

NCT NCT04843631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04843631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Randomised, Double-blind, 3-parallel -Group Phase I Study of BFI-751 Compared With EU-STELARA® and US-STELARA® in Healthy Adult Volunteers
Lead sponsor
BioFactura Australia Pty Ltd.
Phase
Phase 1
Overall status
Completed
Start date
April 1, 2021
Completion date
December 8, 2021
Enrollment
216 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis